Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John L. Higgins Insider Profile
4 Followers
John L. Higgins, Director at Ligand Pharma, holds 48.20K shares in Bio-Techne (Ticker: TECH), holds 2.62M shares in OmniAb (Ticker: OABI), holds 417.69K shares in Ligand Pharma (Ticker: LGND).
Profitable Transactions
8 out of 28 Profitable Transactions
Average Return
-8.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John L. Higgins holds in companies
Most Profitable Insider Trade
The most profitable trade made by John L. Higgins
John L. Higgins's Trading History
Ligand Pharma
Dec 30, 2022
Director
Uninformative Sell
350.61K
$50.38M
OmniAb
Jun 21, 2024
Director
Uninformative Buy
83.80K
$10.89M
Bio-Techne
Oct 28, 2024
Director
Uninformative Buy
―
$3.59M
BioCryst
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see John L. Higgins's performance on stock
You May Also Like
John L. Higgins insider profile FAQ
What is the percentage of profitable transactions made by John L. Higgins?
The percentage of profitable transactions made by John L. Higgins is 29%.
What is the average return per transaction made by John L. Higgins?
The average return per transaction made by John L. Higgins is -8.20%.
What stocks does John L. Higgins hold?
John L. Higgins holds: LGND, OABI, TECH, BCRX stocks.
What was John L. Higgins’s latest transaction?
John L. Higgins latest transaction was an Uninformative Buy of ―.
What was John L. Higgins's most profitable transaction?
John L. Higgins’s most profitable transaction was an Informative Buy of LGND stock on August 15, 2014. The return on the trade was 66.30%.
What is John L. Higgins's role in Ligand Pharma?
John L. Higgins's role in Ligand Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.